Skip to main content
Clinical Trials/NCT00664079
NCT00664079
Terminated
Not Applicable

Thyroid Hormone Deficiency in Critically Ill Children

Children's Hospital of Philadelphia1 site in 1 country22 target enrollmentOctober 2005

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hypotension
Sponsor
Children's Hospital of Philadelphia
Enrollment
22
Locations
1
Primary Endpoint
Certain critically ill children requiring vasoactive infusions and/or mechanical ventilation have low concentrations of tT3, fT3, tT4, fT4, elevated rT3, adn inappropriate low/normal TSH.
Status
Terminated
Last Updated
11 years ago

Overview

Brief Summary

Thyroid hormones are substances naturally made by the body and are important to many of your body's basic functions such as breathing and brain function. We are investigating whether or not these hormones are at lower levels in critically ill children which could lead to further health problems. We hope to get a better understanding of hormone levels and their effects on critically ill children to better help other children in the future.

Detailed Description

We hypothesize that critically ill children that require vasoactive infusions and/or invasive mechanical ventilation have thyroid hormone alterations. We will measure TSH, tT3, fT3, rT3, tT4, fT4, adn tyrosine concentrations in critically ill children with hypotension and/or respiratory failure and correlate thyroid hormone alterations to severity of illness, intensity of therapeutic interventions, and associated morbidity and mortality by using clinical outcomes parameters.

Registry
clinicaltrials.gov
Start Date
October 2005
End Date
December 2008
Last Updated
11 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Informed Consent
  • Age of less than 12 months and less than or equal to 18
  • Patient must weigh greater than 10 kgs.
  • Patients must require vasoactive infusions and/or mechanical ventilation.
  • Patients must be enrolled within 24 hours of meeting eligibility.

Exclusion Criteria

  • Patient with known or presumed pre-existing thyroid disease will be excluded
  • Patients who receive thyroid supplementation will be excluded
  • Patients with known or presumed hypothalamic and/or pituitary dysfunction that have thyroid hormone concentration abnormalities not related to an acute illness.
  • Patients who are intubated for airway protection only.
  • Patients intubated for neuromuscular disease
  • Pregnant patients.
  • Patients receiving amiodarone supplementation
  • Patients who received blood product transfusions equaling more than 1/2 of their blood volume.

Outcomes

Primary Outcomes

Certain critically ill children requiring vasoactive infusions and/or mechanical ventilation have low concentrations of tT3, fT3, tT4, fT4, elevated rT3, adn inappropriate low/normal TSH.

Time Frame: When patient has completed the study.

Secondary Outcomes

  • Critically ill children with more severe thyroid hormone deficiencies will have greater severity of illness, intensity of therapeutic intervention, organ dysfunction, and increased morbidity and mortality.(When study is completed.)
  • Critically ill children requiring vasoactive infusions and/or mechanical ventilation are a population in the ICU that has thyroid hormone pertubation and significant morbidity and mortality.(At completion of study)

Study Sites (1)

Loading locations...

Similar Trials